SPI
17.391,52
PKT
-153,53
PKT
-0,88
%
Werbung
Analysen zu SPI-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 10.09.12 | Swisscom hold | Deutsche Bank AG | |
| 10.09.12 | Nestlé buy | Sarasin Research | |
| 10.09.12 | Roche buy | Banc of America Securities-Merrill Lynch | |
| 10.09.12 | Nestlé kaufen | Norddeutsche Landesbank (Nord/LB) | |
| 10.09.12 | Geberit hold | Vontobel Research | |
| 10.09.12 | Mikron hold | Vontobel Research | |
| 10.09.12 | Newron PharmaceuticalsAz. buy | Vontobel Research | |
| 10.09.12 | Swisscom hold | Vontobel Research | |
| 10.09.12 | Emmi buy | Sarasin Research | |
| 10.09.12 | LEM hold | Vontobel Research | |
| 10.09.12 | Swiss Re buy | Vontobel Research | |
| 07.09.12 | Avolta (ex Dufry) buy | Deutsche Bank AG | |
| 07.09.12 | Roche outperform | Exane-BNP Paribas SA | |
| 07.09.12 | Holcim outperform | Exane-BNP Paribas SA | |
| 07.09.12 | Novartis neutral | J.P. Morgan Cazenove | |
| 07.09.12 | u-blox hold | Vontobel Research | |
| 07.09.12 | StarragTornos hold | Vontobel Research | |
| 06.09.12 | Holcim neutral | J.P. Morgan Cazenove | |
| 06.09.12 | Richemont neutral | J.P. Morgan Cazenove | |
| 06.09.12 | Swiss Re sell | Goldman Sachs Group Inc. | |
| 06.09.12 | Roche overweight | J.P. Morgan Cazenove | |
| 06.09.12 | Novartis neutral | Exane-BNP Paribas SA | |
| 06.09.12 | ABB (Asea Brown Boveri) buy | UBS AG | |
| 06.09.12 | UBS underperform | Cheuvreux SA | |
| 06.09.12 | Holcim outperform | Exane-BNP Paribas SA | |
| 06.09.12 | Holcim outperform | Cheuvreux SA | |
| 06.09.12 | u-blox hold | Vontobel Research | |
| 06.09.12 | Holcim hold | ING | |
| 06.09.12 | Roche buy | Sarasin Research | |
| 06.09.12 | Emmi buy | Sarasin Research | |
| 05.09.12 | Swatch (I) outperform | Credit Suisse Group | |
| 05.09.12 | UBS overweight | J.P. Morgan Cazenove | |
| 05.09.12 | UBS overweight | J.P. Morgan Cazenove | |
| 05.09.12 | Partners Group hold | Vontobel Research | |
| 05.09.12 | Kardex hold | Vontobel Research | |
| 05.09.12 | DKSH hold | Vontobel Research | |
| 05.09.12 | Holcim hold | Vontobel Research | |
| 05.09.12 | Novartis reduce | Vontobel Research | |
| 05.09.12 | Swiss Re buy | Vontobel Research | |
| 05.09.12 | Richemont neutral | Sarasin Research |